Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
olaparib
×
Breast
×
Clear all
Filters
3
NCT04191135
2026-03-03
KEYLYNK-009
Merck Sharp & Dohme LLC
Phase 2
Completed
462 enrolled
30 charts